Google Maps finally comes to iOS. Again [updated]






Apple has had quite a bumpy car ride so far with it’s mapping product. That all ends in just a couple hours, however, because late Wednesday evening Google is planning on bringing Maps back to iOS with the release of the company’s own software. AllThingsD is reporting that Google’s app will be available for download in the App Store shortly, and we’ll provide some initial thoughts on it soon after.


UPDATE: Google Maps is now available on Apple’s App Store for the iPhone, iPad and iPod touch.






Get more from BGR.com: Follow us on Twitter, Facebook


Gadgets News Headlines – Yahoo! News


Read More..

“The Voice” finale taps Rihanna, Kelly Clarkson, Bruno Mars and the Killers






LOS ANGELES (TheWrap.com) – The season finale of “The Voice” has enlisted some high-profile talent to help send the show’s third cycle off with a bang.


Rihanna, Kelly Clarkson, Bruno Mars and The Killers have been tapped to perform on the two-hour extravaganza, which will culminate with the crowning of a new champion, NBC said Wednesday.






An additional special guest will be named at a later date, the network added.


Rihanna will perform her song “Diamonds,” while “American Idol” alum Clarkson – who has served as a guest mentor on the show, as well as hosting the rival singing competition “Duets” – is set to sing “Catch My Breath.”


The Killers, meanwhile, will play their single “Runaways,” and Mars will debut the song “When I Was Your Man” from his sophomore album “Unorthodox Jukebox,” which was released Tuesday.


The season finale of “The Voice” will air live on December 18 at 8 p.m.


Music News Headlines – Yahoo! News


Read More..

Lawmaker: NFL players ‘trying to back out’ on HGH






WASHINGTON (AP) — Accusing the NFL players’ union of “trying to back out” of an August 2011 agreement to start checking for human growth hormone, a congressman worried aloud Wednesday that the league will head into next season without a test for the banned drug.


“Hopefully as we move down the line, players will see how incredibly ridiculous it looks for them not to … straighten this thing out,” said Rep. Elijah Cummings of Maryland, the House Oversight and Government Reform Committee‘s ranking Democrat. “We’re now getting ready to go into a third season, and it does not look very good.”






The panel held a hearing to examine the science behind the testing, and heard from experts that it is reliable.


“No test is perfect … but there hasn’t been a single false positive,” U.S. Anti-Doping Agency Chief Science Officer Larry Bowers testified.


While the latest, 10-year labor contract paved the way for HGH testing in professional football once certain parameters were set, the NFL Players Association wants a new study before it will agree to the validity of a test used by Olympic sports and Major League Baseball. The sides haven’t been able to agree on a scientist to help resolve that impasse.


HGH is a banned substance that is hard to detect and used by athletes for what are believed to be a variety of benefits, whether real or only perceived — such as increasing speed or improving vision. Among the health problems connected to HGH are diabetes, cardiac dysfunction and arthritis.


“They say they need more time … before doing what they agreed to do. To me, it seems obvious the Players Association is simply running out the clock,” Cummings said. “Although they agreed to HGH testing, they are now trying to back out of the contract.”


Cummings and committee chairman Darrell Issa, a California Republican, both said additional hearings are expected.


“It is our hope (to) move these parties closer together,” Issa said.


“This isn’t the players” who are objecting to the test, Issa said after the hearing. “This is lawyers making a statement. Players want to know that the rules are the rules for everybody. … We’re not seeing a vast amount of players stand up. We’re seeing a few lawyers stand up on an unfounded technicality.”


The NFL and union were not invited to testify at the hearing, but representatives of both attended Wednesday’s session.


Asked about Cummings’ comments, NFLPA spokesman George Atallah said after the hearing: “I respect his opinion. We have a contract, and the contract says both sides have to agree to protocols to move forward.”


Atallah said the union was “absolutely not” trying to back out of the agreement on HGH.


NFL senior vice president Adolpho Birch, who oversees the league’s drug program, called the union’s insistence on a population study to determine whether current HGH tests are appropriate for NFL players a delay tactic.


“As a league, we need to look at it in terms of competitive integrity, in terms of being consistent with the NFL having a leadership position in the world of performance-enhancing drugs,” Birch said. “And frankly, I think this delay in implementing this program has put our leadership position at risk.”


Even once scientific issues are resolved, there will be other matters the league and union need to figure out, including who administers the test and what the appeals process will be.


“First, I applaud the NFL and players for taking a bold and decisive position on HGH in their 10-year agreement. Now let’s get on with it,” one witness, Pro Football Hall of Famer Dick Butkus, told the committee Wednesday. “The HGH testing process is proven to be reliable. It’s time to send a clear message that performance-enhancing drugs have no place in sports, especially the NFL.”


___


Connect with Howard Fendrich on Twitter at http://twitter.com/HowardFendrich


___


Online: http://pro32.ap.org/poll and http://twitter.com/AP_NFL


Health News Headlines – Yahoo! News


Read More..

Stock futures point to flat-to-lower start






LONDON (Reuters) – Stock futures pointed to a flat-to-lower open on Wall Street on Thursday, with futures for the S&P 500 down 0.1 percent at 0950 GMT (4.50 a.m. ET).


Contracts on the Dow Jones and the Nasdaq 100 were flat in percentage terms.






Japan’s Nikkei <.n225> average surged above 9,700 for the first time in eight months, led by exporters, as the yen fell to a multi-month low on mounting expectations of aggressive monetary easing by the Bank of Japan after a general election at the weekend.</.n225>


European shares slipped on Thursday after persistent concern about U.S. austerity measures that could hit growth in the world’s largest economy overshadowed fresh stimulus steps from the Federal Reserve.


Google’s navigation tool has returned to the iPhone, months after Apple‘s home-grown mapping service flopped, prompting user complaints, the firing of an executive and a public apology from Apple‘s CEO. [ID:nL1E8ND0P2]


Adobe Systems , the maker of Photoshop software, reports results, expected to show earnings per share fell to $ 0.57 in its fourth quarter, from $ 0.67 one year earlier.


GrainCorp Ltd on Thursday rejected a sweetened $ 2.9 billion bid from Archer Daniels Midland , putting pressure on the U.S. agribusiness giant to boost its offer for Australia’s last major independent grains handler.


Knight Capital Group Inc expects to make a decision on its future ownership by early next week, the Wall Street Journal reported on Thursday, citing people familiar with the matter.


The U.S. unit of Britain’s BAE Systems Plc said it has won a contract valued at up to $ 400 million to maintain and service more than 300 U.S. Navy trainer aircraft, beating out incumbent Sikorsky Aircraft, a unit of United Technologies , and L-3 Communications .


The Pentagon will pay about 4 percent less for each new Lockheed Martin Corp F-35A fighter jet when it signs a deal worth $ 3.8 billion with the No. 1 U.S. defense contractor on Friday, according to sources familiar with the deal.


American Airlines creditors want a potential merger with US Airways Group Inc to be an all-stock deal rather than one that pays some claims in cash, three people familiar with the matter said, in a move that underscores confidence in a merged airline.


Solar installer SolarCity is set to begin trading on the Nasdaq after halving the value of its initial public offering. The deal has been highly anticipated in clean tech and venture capital circles as alternative energy startups have had a difficult time attracting investor interest.


The U.S. Labor Dept releases first-time claims for jobless benefits for the week ended December 8 at 1330 GMT (8.30 a.m. ET). They were expected to show 370,000 new filings, a repeat of the previous weeks figure.


The U.S. Commerce Dept’s November retail sales, also due out 1330 GMT (8.30 a.m. ET), were forecast to show a 0.5 percent rise, compared with a 0.3 percent decrease in October. Excluding automobiles, sales are expected to be unchanged, a repeat of the October level.


Producer prices were forecast to show a 0.5 percent decrease compared with a 0.2 percent drop in October. Excluding volatile food and energy items, PPI is expected to rise 0.2 percent versus with a 0.2 percent decrease in October.


The Dow Jones industrial average <.dji> slipped 2.99 points, or 0.02 percent, to 13,245.45 on Wednesday. The Standard & Poor’s 500 Index <.spx> inched up just 0.64 of a point, or 0.04 percent, to 1,428.48. But the Nasdaq Composite Index <.ixic> shed 8.49 points, or 0.28 percent, to end at 3,013.81.</.ixic></.spx></.dji>


(Reporting By Francesco Canepa. Editing by Jeremy Gaunt.)


Business News Headlines – Yahoo! News


Read More..

Pope Benedict offers blessings with his first tweet






VATICAN CITY (Reuters) – After weeks of anticipation, Pope Benedict sent his first tweet on Wednesday.


“Dear friends, I am pleased to get in touch with you through Twitter. Thank you for your generous response. I bless all of you from my heart.”






The tweet was sent when the 85-year-old pope tapped on a touch screen at the end of his weekly general audience in the Vatican before thousands of people.


(Reporting By Philip Pullella, editing by Paul Casciato)


Internet News Headlines – Yahoo! News


Read More..

Anthony Jeselnik, Amy Schumer, Nick Kroll Shows get Comedy Central premiere dates






NEW YORK (TheWrap.com) – Comedy Central has set premiere dates for new series starring comedians Anthony Jeselnik, Amy Schumer, Nick Kroll, Ben Hoffman and Nathan Fielder.


The biting Jeselnik and Schumer are familiar to fans of Comedy Centrals celebrity roasts: They reliably deliver some of the most scathing and best-assembled insults. Nick Kroll stars on FX’s “The League.” And Hoffman and Fielder will both lure unassuming, regular people into their shows, airing together on Thursdays.






Comedy Central made the announcements as it released its midseason schedule Tuesday.


The sketch series “Kroll Show” premieres Wednesday, January 16 at 10:30 p.m. “The Jeselnik Offensive” debuts Tuesday, February 19 at 10:30 p.m., and will take on the week’s train wrecks in the news.


The sketch/man on the street series “The Ben Show,” starring Hoffman, premieres Thursday, February 28 at 10 p.m. It will be followed at 10:30 by Fielder’s “Nathan For You,” which “draws real people into an experience far beyond what they signed up for, according to Comedy Central.


Schumer looks at “sex, relationships, and the general clusterf— that is life” in “Inside Amy Schumer,” beginning Tuesday, April 30 at 10:30 p.m.


The network also announced standup specials for Jeselnik on Sunday, January 13, Kristen Schaal on Friday, January 18, and Katt Williams on Saturday, February 23. (Williams has popped up lately for a string of run-ins with the law, but he’s also famous for telling jokes.)


Comedy Central also set several return dates. Roastmaster Jeff Ross is back for season 2 of “The Burn With Jeff Ross” on Tuesday, January 8 at 10:30 p.m. “Workaholics” clocks in again on Wednesday, January 16 at 10 p.m., and the fifth season of “Tosh.0″ premieres Tuesday, February 5 at 10 p.m.


TV News Headlines – Yahoo! News


Read More..

AstraZeneca partners with Isis Pharma to develop cancer therapies






(Reuters) – Isis Pharmaceuticals Inc struck a deal with British drugmaker AstraZeneca Plc to develop its novel technology against five cancer targets.


In exchange for $ 31 million in upfront and near-term payments to Isis, AstraZeneca will co-develop four oncology research programs and get the rights to develop and commercialize a drug that is in early trials for patients with advanced lymphomas.






Isis’s antisense therapies work by destroying the RNA that creates proteins involved in disease processes.


“Isis’ antisense technology platform allows AstraZeneca to broaden our oncology research efforts beyond traditional drug discovery methods, while at the same time becoming more specific about how we target cancer,” said Susan Galbraith, head of the AstraZeneca Oncology Innovative Medicines Unit.


Isis is also eligible to receive further payments on clinical and approval milestones, license fees for research program targets and royalties on sales.


Shares of Isis rose about 2 percent before the bell. They closed at $ 9.42 on Monday on the Nasdaq.


(Reporting by Prateek Kumar; Editing by Saumyadeb Chakrabarty)


Diseases/Conditions News Headlines – Yahoo! News


Read More..

Stock futures edge higher, focus on Fed






LONDON (Reuters) – Stock futures pointed to a fractionally higher open on Wall Street on Wednesday, with futures for the S&P 500, the Dow Jones and the Nasdaq 100 rising by 0.1 to 0.2 percent.


* The U.S. Federal Reserve is expected to announce a fresh round of bond buying on Wednesday as part of its efforts to support a fragile economic recovery threatened by political wrangling over the government’s budget.






* Negotiations to avert the “fiscal cliff” ahead of a year-end deadline intensified as President Barack Obama and U.S. House of Representatives Speaker John Boehner spoke by phone on Tuesday after exchanging new proposals.


* India’s government announced an inquiry into lobbying practices by Wal-Mart Stores Inc. on Wednesday after a report that the giant retailer had pressed U.S. lawmakers to help gain access to foreign markets.


* Costco Wholesale Corp posted a 30 percent rise in quarterly profit, beating expectations, as the largest U.S. warehouse club chain saw sales rise and got a lift from higher membership fees.


* Chesapeake Energy Corp on Tuesday agreed to sell most of its remaining natural gas processing and gathering assets for $ 2.16 billion as it continues to sell assets to pay down its heavy debt load.


* Sprint Nextel Corp is in talks with Intel Corp and Comcast Corp to buy out their stakes in the U.S. wireless provider Clearwire Corp , two people familiar with the matter said on Tuesday.


* European shares steadied in early trade on Wednesday, keeping alive their sharp three-week rally as investors bet the Fed would deliver on stimulus.


* The Dow Jones industrial average <.dji> closed up 78.56 points, or 0.60 percent, at 13,248.44 on Tuesday. The Standard & Poor’s 500 Index <.spx> was up 9.29 points, or 0.65 percent, at 1,427.84 – its highest since November elections. The Nasdaq Composite Index <.ixic> was up 35.34 points, or 1.18 percent, at 3,022.30.</.ixic></.spx></.dji>


(Reporting by Atul Prakash; editing by Patrick Graham)


Business News Headlines – Yahoo! News


Read More..

Australian prank call radio to donate profits to nurse’s family






CANBERRA (Reuters) – The Australian radio station behind a prank call to a British hospital will donate its advertising revenue until the end of the year to a fund for the family of the nurse who apparently took her own life after the stunt, the company said on Tuesday.


Southern Cross Austereo, parent company of Sydney radio station 2Day FM, said it would donate all advertising revenue, with a minimum contribution of A$ 500,000 ($ 525,000), to a memorial fund for the nurse, Jacintha Saldanha, who answered the telephone at the hospital treating Prince William’s pregnant wife, Kate.






The company has suspended the Sydney-based announcers, Mel Greig and Michael Christian, scrapped their “Hot 30″ programme and suspended advertising on the station in the wake of the Saldanha’s death. Southern Cross said it would resume advertising on its station from Thursday.


“It is a terrible tragedy and our thoughts continue to be with the family,” Southern Cross Chief Executive Officer Rhys Holleran said in a statement.


“We hope that by contributing to a memorial fund we can help to provide the Saldanha family with the support they need at this very difficult time.”


(Reporting by James Grubel; Editing by Robert Birsel)


Europe News Headlines – Yahoo! News


Read More..

AstraZeneca starts mid-stage TB drug trial in South Africa






LONDON (Reuters) – A new experimental drug that may fight drug-resistant strains of the lung disease tuberculosis is being tested in South Africa, where the first patient has been enrolled into a mid-stage clinical trial.


AstraZeneca, which developed the medicine known as AZD5847, is working with the U.S. National Institute of Allergy and Infectious Diseases and Case Western Reserve University School of Medicine on the Phase IIa clinical study.






Scientists have found an alarming number of cases of TB that are resistant to many of the most powerful existing antibiotic drugs, underlining the need for new treatments.


AstraZeneca’s new drug is still several years from reaching the market. Even if it works in the trial, further tests will still be needed before it is approved for use.


The British drugmaker said on Tuesday it planned to test AZD5847 in further clinical trials as part of one or more next-generation combination therapies against TB.


(Reporting by Ben Hirschler; Editing by Helen Massy-Beresford)


Medications/Drugs News Headlines – Yahoo! News


Read More..